U.S. markets closed
  • S&P 500

    3,426.92
    -56.89 (-1.63%)
     
  • Dow 30

    28,195.42
    -410.89 (-1.44%)
     
  • Nasdaq

    11,478.88
    -192.67 (-1.65%)
     
  • Russell 2000

    1,613.63
    -20.18 (-1.24%)
     
  • Crude Oil

    40.64
    -0.19 (-0.47%)
     
  • Gold

    1,905.70
    -6.00 (-0.31%)
     
  • Silver

    24.48
    -0.22 (-0.90%)
     
  • EUR/USD

    1.1769
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    0.7610
    +0.0170 (+2.28%)
     
  • GBP/USD

    1.2947
    +0.0007 (+0.05%)
     
  • USD/JPY

    105.4370
    +0.0070 (+0.01%)
     
  • BTC-USD

    11,729.32
    +672.31 (+6.08%)
     
  • CMC Crypto 200

    239.16
    +5.49 (+2.35%)
     
  • FTSE 100

    5,884.65
    -34.93 (-0.59%)
     
  • Nikkei 225

    23,671.13
    +260.50 (+1.11%)
     

Nasdaq Scheduled Resumption in Organogenesis Holdings Inc.

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NDAQ) announced that trading in Organogenesis Holdings Inc. (ORGO) is scheduled to resume on Tuesday, January 8, 2019, at 7:15 a.m. Eastern Time. Trading in the company’s stock was halted on October 30, 2018 at 17:05:35 p.m. Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Emily Pan
emily.pan@nasdaq.com